Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -26.88% is 80% below its 5-year average of -14.94%, near the low end of its 5-year range (-32.15%–0.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.10% below its 12-month average of -23.35%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -26.88%.
RETURN ON INVESTED CAPITAL (ROIC)
-26.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-23.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-20.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-14.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-14.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.10%
CURRENT VS 3Y AVG
-29.57%
CURRENT VS 5Y AVG
-79.89%
CURRENT VS 10Y AVG
-85.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 681 covered companies
CURRENT VS SECTOR MEDIAN
+21.19%
vs the sector median at left
Novocure Ltd
Market Cap
$1.84B
Return on Invested Capital (ROIC)
-26.88%
TTM Avg
-23.35%
3Y Avg
-20.74%
5Y Avg
-14.94%
Market Cap
$1.84B
Return on Invested Capital (ROIC)
-52.66%
TTM Avg
-61.09%
3Y Avg
-54.75%
5Y Avg
-42.45%
Market Cap
$1.84B
Return on Invested Capital (ROIC)
4.13%
TTM Avg
4.21%
3Y Avg
5.71%
5Y Avg
5.17%
Market Cap
$1.82B
Return on Invested Capital (ROIC)
9.81%
TTM Avg
8.38%
3Y Avg
8.16%
5Y Avg
8.82%
Market Cap
$1.86B
Return on Invested Capital (ROIC)
-23.90%
TTM Avg
-49.28%
3Y Avg
-183.01%
5Y Avg
-156.37%
Market Cap
$1.88B
Return on Invested Capital (ROIC)
-36.37%
TTM Avg
8.48%
3Y Avg
-213.38%
5Y Avg
-299.96%
Market Cap
$1.88B
Return on Invested Capital (ROIC)
-1.33%
TTM Avg
-1.10%
3Y Avg
-1.49%
5Y Avg
-1.29%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-1.08%
3Y Avg
-2.19%
5Y Avg
-2.71%
Market Cap
$1.79B
Return on Invested Capital (ROIC)
-94.79%
TTM Avg
-70.21%
3Y Avg
-70.21%
5Y Avg
-70.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novocure Ltd (NVCR) | $1.84B | -26.88% | -23.35% | -20.74% | -14.94% |
| Absci Corporation (ABSI)vs › | $1.84B | -52.66% | -61.09% | -54.75% | -42.45% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 4.13% | 4.21% | 5.71% | 5.17% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 9.81% | 8.38% | 8.16% | 8.82% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | -23.90% | -49.28% | -183.01% | -156.37% |
| Novavax, Inc. (NVAX)vs › | $1.88B | -36.37% | 8.48% | -213.38% | -299.96% |
| Azenta, Inc. (AZTA)vs › | $1.88B | -1.33% | -1.10% | -1.49% | -1.29% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 1.72% | -1.08% | -2.19% | -2.71% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | -94.79% | -70.21% | -70.21% | -70.21% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -44.21% | -32.05% | -35.56% | -35.59% |
ROIC
-26.9%
ROE
-43.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -26.88% |
| 2026-03-31 | -32.15% |
| 2025-12-31 | -25.95% |
| 2025-09-30 | -15.42% |
| 2025-06-30 | -16.36% |
| 2025-03-31 | -15.68% |
| 2024-12-31 | -16.36% |
| 2024-09-30 | -15.22% |
| 2024-06-30 | -17.75% |
| 2024-03-31 | -22.28% |
| 2023-12-31 | -24.08% |
| 2023-09-30 | -22.66% |
| 2023-06-30 | -18.88% |
| 2023-03-31 | -14.53% |
| 2022-12-31 | -8.67% |
| 2022-09-30 | -6.77% |
| 2022-06-30 | -5.25% |
| 2022-03-31 | -4.41% |
| 2021-12-31 | -4.42% |
| 2021-09-30 | -0.89% |
| 2021-06-30 | 0.83% |
| 2021-03-31 | 1.95% |
| 2020-12-31 | 3.22% |
| 2020-09-30 | 5.50% |
| 2020-06-30 | 1.64% |
| 2020-03-31 | 0.44% |
| 2019-12-31 | -0.23% |
| 2019-09-30 | -2.68% |
| 2019-06-30 | -5.66% |
| 2019-03-31 | -7.97% |
| 2018-12-31 | -12.23% |
| 2018-09-30 | -11.04% |
| 2018-06-30 | -11.41% |
| 2018-03-31 | -14.93% |
| 2017-12-31 | -18.28% |
| 2017-09-30 | -23.81% |
| 2017-06-30 | -33.82% |
| 2017-03-31 | -41.58% |
| 2016-12-31 | -47.03% |
| 2016-09-30 | -48.99% |
| 2016-06-30 | -57.44% |
| 2016-03-31 | -45.67% |
| 2015-12-31 | -37.31% |
| 2015-09-30 | -65.19% |
| 2015-06-30 | -52.82% |
| 2015-03-31 | -81.31% |
| 2014-12-31 | -79.98% |
